Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients (AXaLPE): protocol of a randomised, open-label controlled clinical trial.

Wang, Chunmei; Ning, Ya-Chan; Song, Li-Po; Li, Pei-Juan; Wang, Feng-Hua; Ding, Meng-Xi; Jiang, Li; Wang, Meiping; Pei, Qian-Qian; Hu, Shi-Min; Wang, Haibo

Wang, Chunmei; Ning, Ya-Chan; Song, Li-Po; Li, Pei-Juan; Wang, Feng-Hua; Ding, Meng-Xi; Jiang, Li; Wang, Meiping; Pei, Qian-Qian; Hu, Shi-Min; Wang, Haibo.

Afiliação

Wang C; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Ning YC; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Song LP; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Li PJ; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Wang FH; Department of Emergency, PLA Rocket Force Characteristic Medical Center, Beijing, China.
Ding MX; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Jiang L; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Wang M; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Pei QQ; Department of General Practice, Aerospace Center Hospital, Beijing, China.
Hu SM; Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China hbwang2005@163.com hushimin@xwhosp.org.
Wang H; Beijing Key Laboratory of Neuromodulation, Beijing, China.

BMJ Open ; 13(10): e069742, 2023 10 25.

Article em En | MEDLINE | ID: mdl-37880168

Assuntos

Heparina de Baixo Peso Molecular; Tromboembolia Venosa; Humanos; Anticoagulantes/uso terapêutico; Estado Terminal/terapia; Enoxaparina/uso terapêutico; Heparina; Heparina de Baixo Peso Molecular/uso terapêutico; Ensaios Clínicos Controlados Aleatórios como Assunto; Tromboembolia Venosa/tratamento farmacológico; Inibidores do Fator Xa/sangue

Palavras-chave

Adult intensive & critical care; Anticoagulation; INTENSIVE & CRITICAL CARE; Thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heparina de Baixo Peso Molecular / Tromboembolia Venosa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google